RU98112369A - METHOD FOR TREATING CHRONIC INFLAMMATORY DERMATOSIS IN CHILDREN - Google Patents

METHOD FOR TREATING CHRONIC INFLAMMATORY DERMATOSIS IN CHILDREN

Info

Publication number
RU98112369A
RU98112369A RU98112369/14A RU98112369A RU98112369A RU 98112369 A RU98112369 A RU 98112369A RU 98112369/14 A RU98112369/14 A RU 98112369/14A RU 98112369 A RU98112369 A RU 98112369A RU 98112369 A RU98112369 A RU 98112369A
Authority
RU
Russia
Prior art keywords
drug
week
tablets
dose
day
Prior art date
Application number
RU98112369/14A
Other languages
Russian (ru)
Other versions
RU2175244C2 (en
Inventor
Н.С. Смирнова
Э.Б. Татулов
Д.Л. Зубов
В.В. Дьякова
Ю.Н. Кошевенко
Original Assignee
Н.С. Смирнова
Э.Б. Татулов
Д.Л. Зубов
Filing date
Publication date
Application filed by Н.С. Смирнова, Э.Б. Татулов, Д.Л. Зубов filed Critical Н.С. Смирнова
Priority to RU98112369A priority Critical patent/RU2175244C2/en
Priority claimed from RU98112369A external-priority patent/RU2175244C2/en
Publication of RU98112369A publication Critical patent/RU98112369A/en
Application granted granted Critical
Publication of RU2175244C2 publication Critical patent/RU2175244C2/en

Links

Claims (4)

1. Способ лечения хронических воспалительных дерматозов у детей заключается в проведении ферментотерапии с использованием полиэнзимного препарата в виде драже в кишечнорастворимой оболочке, содержащего в одном драже энзимы животного происхождения (панкреатин - 100 мг, химотрипсин - 1 мг, трипсин - 24 мг, амилаза - 10 мг, липаза - 10 мг), энзимы растительного происхождения (бромелаин - 45 мг, папаин - 60 мг), рутин - 50 мг, в дозе от 3 до 9 драже в день в зависимости от возраста.1. A method of treating chronic inflammatory dermatoses in children is enzyme therapy using a polyenzyme preparation in the form of an enteric-coated tablet containing enzymes of animal origin in one tablet (pancreatin - 100 mg, chymotrypsin - 1 mg, trypsin - 24 mg, amylase - 10 mg, lipase - 10 mg), enzymes of plant origin (bromelain - 45 mg, papain - 60 mg), rutin - 50 mg, in a dose of 3 to 9 tablets per day, depending on age. 2. Способ по п.1 больным детям в возрасте от 3 лет до 7 препарат в течение первых 3 недель назначают по 3 драже в день; в течение 4-й недели - по 4 драже в день; с 5-й недели и далее в течение 1,5-2 месяцев - по 5 драже в день, затем при наличии положительной динамики в клинической картине болезни производится снижение дозы препарата по 1 драже в неделю в обратном порядке. 2. The method according to claim 1, for sick children aged 3 years to 7, the drug is prescribed 3 tablets per day for the first 3 weeks; during the 4th week - 4 tablets per day; from the 5th week and then for 1.5-2 months - 5 tablets a day, then if there is a positive dynamics in the clinical picture of the disease, the dose of the drug is reduced by 1 tablet per week in the opposite order. 3. Способ по п.1 больным детям в возрасте от 7 лет до 11 препарат в течение первых 3 недель назначают по 3 драже в день; с 4-й по 7 неделю дозу препарата увеличивают еженедельно на 1 драже; с 7-й недели и далее в течение 1,5-2 месяцев - по 7 драже в день, затем при наличии положительной динамики в клинической картине болезни производится снижение дозы препарата по 1 драже в неделю в обратном порядке. 3. The method according to claim 1, for sick children aged 7 to 11, the drug is prescribed 3 tablets per day for the first 3 weeks; from the 4th to 7th week, the dose of the drug is increased weekly by 1 dragee; from the 7th week and then for 1.5-2 months - 7 tablets a day, then if there is a positive dynamics in the clinical picture of the disease, the dose of the drug is reduced by 1 tablet per week in the opposite order. 4. Способ по п.1 больным детям в возрасте от 11 лет до 14 лет 11 месяцев в течение первых 3 недель препарат назначают по 3 драже в день; с 4-й по 9 неделю дозу препарата увеличивают еженедельно на 1 драже; с 9-й недели далее в течение 1,5-2 месяцев препарат дают по 9 драже в день, затем при наличии положительной динамики в клинической картине болезни производится снижение дозы препарата по 1 драже в неделю в обратном порядке. 4. The method according to claim 1 for sick children aged 11 years to 14 years 11 months during the first 3 weeks, the drug is prescribed 3 tablets a day; from the 4th to the 9th week, the dose of the drug is increased weekly by 1 dragee; from the 9th week, for 1.5-2 months, the drug is given 9 tablets a day, then if there is positive dynamics in the clinical picture of the disease, the dose of the drug is reduced by 1 tablet per week in the opposite order.
RU98112369A 1998-06-22 1998-06-22 Method of treating chronic inflammatory dermatoses in children RU2175244C2 (en)

Priority Applications (1)

Application Number Priority Date Filing Date Title
RU98112369A RU2175244C2 (en) 1998-06-22 1998-06-22 Method of treating chronic inflammatory dermatoses in children

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
RU98112369A RU2175244C2 (en) 1998-06-22 1998-06-22 Method of treating chronic inflammatory dermatoses in children

Publications (2)

Publication Number Publication Date
RU98112369A true RU98112369A (en) 2000-03-10
RU2175244C2 RU2175244C2 (en) 2001-10-27

Family

ID=20207805

Family Applications (1)

Application Number Title Priority Date Filing Date
RU98112369A RU2175244C2 (en) 1998-06-22 1998-06-22 Method of treating chronic inflammatory dermatoses in children

Country Status (1)

Country Link
RU (1) RU2175244C2 (en)

Similar Documents

Publication Publication Date Title
JP2733849B2 (en) Improved method for treating gastrointestinal disorders
US20060269619A1 (en) Nutrient system for individualized responsive dosing regimens
RU99101790A (en) METHOD FOR TREATING URINE INCOMPOSITION USING (S) -OXIBUTININ AND (S) -DESETHYLOXIBUTININ
DE3856435T2 (en) Use of bile acid activated lipase as a dietary supplement
Kirkpatrick et al. Treatment of chronic oral candidiasis with clotrimazole troches: a controlled clinical trial
Griessen et al. Calcium absorption from milk in lactase-deficient subjects
CA2257121A1 (en) Methods and compositions for treating urinary incontinence using optically pure (s)-oxybutynin
IL130041A (en) Ferric citrate and/or ferric acetate for controlling phosphate retention in hyperphosphatemia patients
HK72387A (en) Orally administrable antidiabetic compositions
Kesavan et al. Folate malabsorption in aged rats related to low levels of pancreatic folyl conjugase
WO1999000135A1 (en) Composition comprising vitamin k and vitamin d, for treating or preventing osteoporosis
CA2132427A1 (en) Method and composition for suppresion of side effects of anti-inflammatory drugs
RU98112369A (en) METHOD FOR TREATING CHRONIC INFLAMMATORY DERMATOSIS IN CHILDREN
Abdullah et al. Acute pancreatitis secondary to 5-aminosalicylic acid in a child with ulcerative colitis
RU98112367A (en) METHOD FOR TREATING REACTIVE PANCREATITIS IN CHILDREN
KALES et al. Effect of divided calcium intake on calcium metabolism
Sweany et al. A preliminary report on the use of para-amino salicylic acid in the treatment of pulmonary tuberculosis
KR880010762A (en) Composition and Method for Treatment of peptic Ulcers
JPS646214A (en) Remedy for ulcerative colonopathy
Cheraskin et al. Effect of regular versus sustained-release multivitamin supplementation upon periodontal parameters. 2. Sulcus depth and clinical tooth mobility
RU95102718A (en) Method of immune status correction in hiv-infected patients
Arthur et al. Digestion and enzymes
Hurwitz et al. Gastric Hypochlorhydria and Achlorhydria in Older Adults-Reply
SU1703115A1 (en) Method for treating the cases of active rickets
KR20060011615A (en) Medicines of alendronic acid having improved bioavailability